Brazilian HTA drive "a challenge", says Anvisa quality assurance expert
This article was originally published in Clinica
“The implantation of health technology assessment (HTA) in Brazil is proving to be a challenge,” according to Clarice Petramale, co-ordinator of the vigilance unit of regulatory agency Anvisa, in comments appraising current efforts to improve purchasing quality and cost-effectiveness. She was speaking at the 10th “sentinel hospitals” conference, in São Paulo, which was centred on the themes of HTA and patient safety.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.